Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
76.83
-0.04 (-0.05%)
Market open: Aug 12, 2026, 3:06 PM EDT
76.90
+0.03 (0.04%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
There is no data to display
| Date | Type | Document |
|---|---|---|
| 2026-08-06 | SC TO-T | ny20079488x1_sctot.htm |
| 2026-08-06 | SC 14D9 | ny20079529x1_sc14d9.htm |
| 2026-07-28 | SC TO-C | tm2621326d3_sctoc.htm |
| 2026-07-27 | SC14D9C | d135628dsc14d9c.htm |
| 2026-07-27 | 8-K | d31466d8k.htm |
| 2026-07-09 | 8-K | d170175d8k.htm |
| 2026-06-08 | S-3/A | d117004ds3a.htm |
| 2026-06-02 | S-8 | d13894ds8.htm |
| 2026-06-02 | S-3 | d117004ds3.htm |
| 2026-06-02 | 8-K | d110060d8k.htm |